Shots:Matt spoke about the new research program for multiple genetic segments of arrhythmogenic cardiomyopathyHe also highlighted Renovacor’s research collaboration with the University of Utah’s Nora Eccles Harrison Cardiovascular Research and Training Institute (CVRTI)The interview shows Renovacor’s pipeline expansion to develop transformative therapies in genetically-driven cardiovascular diseasesSmriti: Please give readers a brief insight…
